-
D658892-5mgDisitertide (P144) diammonium is a peptidic transforming growth factor-beta 1 (TGF-β1) inhibitor specifically designed to block the interaction with its receptor. Disitertide diammonium is also a PI3K inhibitor and an apoptosis
-
D651543-100mgDK419 is a potent and orally active Wnt/β-catenin signaling inhibitor, with an IC 50 of 0.19 μM. DK419 reduces protein lelvels of Axin2, β-catenin , c-Myc , Cyclin D1 and Survivin and induces production of pAMPKForm:SolidIC50&
-
D651543-10mgDK419 is a potent and orally active Wnt/β-catenin signaling inhibitor, with an IC 50 of 0.19 μM. DK419 reduces protein lelvels of Axin2, β-catenin , c-Myc , Cyclin D1 and Survivin and induces production of pAMPKForm:SolidIC50&
-
D651543-1mgDK419 is a potent and orally active Wnt/β-catenin signaling inhibitor, with an IC 50 of 0.19 μM. DK419 reduces protein lelvels of Axin2, β-catenin , c-Myc , Cyclin D1 and Survivin and induces production of pAMPKForm:SolidIC50&
-
D651543-50mgDK419 is a potent and orally active Wnt/β-catenin signaling inhibitor, with an IC 50 of 0.19 μM. DK419 reduces protein lelvels of Axin2, β-catenin , c-Myc , Cyclin D1 and Survivin and induces production of pAMPKForm:SolidIC50&
-
D651543-5mgDK419 is a potent and orally active Wnt/β-catenin signaling inhibitor, with an IC 50 of 0.19 μM. DK419 reduces protein lelvels of Axin2, β-catenin , c-Myc , Cyclin D1 and Survivin and induces production of pAMPKForm:SolidIC50&
-
D656717-1mlDK419 is a potent and orally active Wnt/β-catenin signaling inhibitor, with an IC 50 of 0.19 μM. DK419 reduces protein lelvels of Axin2, β-catenin , c-Myc , Cyclin D1 and Survivin and induces production of pAMPKIC50& Target:Wnt/β-catenin
-
D647187-10mgDMU-212 is a methylated derivative of Resveratrol ( HY-16561 ), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212
-
D647187-25mgDMU-212 is a methylated derivative of Resveratrol ( HY-16561 ), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212
-
D647187-50mgDMU-212 is a methylated derivative of Resveratrol ( HY-16561 ), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212
-
D647187-5mgDMU-212 is a methylated derivative of Resveratrol ( HY-16561 ), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212
-
D654908-1mlDMU-212 is a methylated derivative of Resveratrol ( HY-16561 ), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212